Share on StockTwits

Edap Tms SA (NASDAQ:EDAP) released its earnings data on Thursday. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.28, American Banking reports. The company had revenue of $7.70 million for the quarter, compared to the consensus estimate of $10.32 million.

Edap Tms SA (NASDAQ:EDAP) opened at 1.68 on Thursday. Edap Tms SA has a 52-week low of $1.38 and a 52-week high of $6.05. The stock has a 50-day moving average of $3.19 and a 200-day moving average of $3.38. The company’s market cap is $36.6 million. Edap Tms SA also saw a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 647,824 shares, a decline of 54.8% from the July 31st total of 1,433,149 shares. Based on an average daily volume of 925,889 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.0% of the shares of the stock are short sold.

A number of analysts have recently weighed in on EDAP shares. Analysts at Northland Securities cut their price target on shares of Edap Tms SA to $2.00 in a research note on Thursday, July 31st. Finally, analysts at HC Wainwright initiated coverage on shares of Edap Tms SA in a research note on Monday, June 16th. They set a “buy” rating and a $6.00 price target on the stock.

Edap Tms SA (NASDAQ:EDAP) is engaged in developing and marketing the Ablatherm device, an advanced choice for high intensity focused ultrasound (HIFU) treatment of localized prostate cancer.

Receive News & Ratings for Edap Tms SA (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms SA (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.